1
|
Vyunova TV, Andreeva LA, Shevchenko KV, Glazova NY, Sebentsova EA, Levitskaya NG, Myasoedov NF. Synthetic corticotropins and the GABA-receptor system: Direct and delayed effects. Chem Biol Drug Des 2023; 101:1393-1405. [PMID: 36828803 DOI: 10.1111/cbdd.14221] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/28/2022] [Revised: 01/16/2023] [Accepted: 02/13/2023] [Indexed: 02/26/2023]
Abstract
The central effectors of the stress system are greatly interconnected and include, among others, a large group of peptides derived from proopiomelanocortin. In addition to natural corticotropins, a number of artificial molecules that contain some ACTH fragments in their structure are also referred to members of this family. Some of them possess a wide range of biological activity. The molecular mechanism underlying the biological activity of such peptides is partly based on allosteric modulation of various receptors. We analyzed the ability of some biologically active synthetic corticotropins (ACTH(4-7)PGP, ACTH(6-9)PGP, ACTH(7-10)PGP), and glyproline PGPL to affect the GABA-receptor system of rat brain. The effects of the peptides were studied in the isolated plasma membranes of brain cells, as well as after systemic peptide administration in the rat model of acute restraint stress. The delayed effect of stress or preadministration of each of the studied peptides on [3 H]GABA binding was different for its high- and low-affinity-specific sites. The studied peptides individually affected the binding of [3 H]GABA in their own way. Acute restraint stress caused a decrease in [3 H]GABA binding at its low-affine site and did not affected the high-affine site. Preliminary peptide administration did not influence this effect of stress.
Collapse
Affiliation(s)
- Tatiana V Vyunova
- Institute of Molecular Genetics of National Research Centre «Kurchatov Institute», Moscow, Russia
| | - Ludmila A Andreeva
- Institute of Molecular Genetics of National Research Centre «Kurchatov Institute», Moscow, Russia
| | - Konstantin V Shevchenko
- Institute of Molecular Genetics of National Research Centre «Kurchatov Institute», Moscow, Russia
| | - Nataliya Yu Glazova
- Institute of Molecular Genetics of National Research Centre «Kurchatov Institute», Moscow, Russia.,Faculty of Biology, Moscow State University, Moscow, Russia
| | - Elena A Sebentsova
- Institute of Molecular Genetics of National Research Centre «Kurchatov Institute», Moscow, Russia.,Faculty of Biology, Moscow State University, Moscow, Russia
| | - Natalia G Levitskaya
- Institute of Molecular Genetics of National Research Centre «Kurchatov Institute», Moscow, Russia.,Faculty of Biology, Moscow State University, Moscow, Russia
| | - Nikolay F Myasoedov
- Institute of Molecular Genetics of National Research Centre «Kurchatov Institute», Moscow, Russia.,The Mental Health Research Center of the Russian Academy of Medical Sciences, Moscow, Russia
| |
Collapse
|
2
|
Stavchansky VV, Filippenkov IB, Remizova JA, Denisova AE, Mozgovoy IV, Gubsky LV, Myasoedov NF, Andreeva LA, Limborska SA, Dergunova LV. Insight into Glyproline Peptides' Activity through the Modulation of the Inflammatory and Neurosignaling Genetic Response Following Cerebral Ischemia-Reperfusion. Genes (Basel) 2022; 13. [PMID: 36553646 DOI: 10.3390/genes13122380] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/04/2022] [Revised: 12/10/2022] [Accepted: 12/13/2022] [Indexed: 12/24/2022] Open
Abstract
Glyprolines are Gly-Pro (GP)- or Pro-Gly (PG)-containing biogenic peptides. These peptides can act as neutrophil chemoattractants, or atheroprotective, anticoagulant, and neuroprotective agents. The Pro-Gly-Pro (PGP) tripeptide is an active factor of resistance to the biodegradation of peptide drugs. The synthetic Semax peptide, which includes Met-Glu-His-Phe (MEHF) fragments of adrenocorticotropic hormone and the C-terminal tripeptide PGP, serves as a neuroprotective drug for the treatment of ischemic stroke. Previously, we revealed that Semax mostly prevented the disruption of the gene expression pattern 24 h after a transient middle cerebral artery occlusion (tMCAO) in a rat brain model. The genes of this pattern were grouped into an inflammatory cluster (IC) and a neurotransmitter cluster (NC). Here, using real-time RT-PCR, the effect of other PGP-containing peptides, PGP and Pro-Gly-Pro-Leu (PGPL), on the expression of a number of genes in the IC and NC was studied 24 h after tMCAO. Both the PGP and PGPL peptides showed Semax-unlike effects, predominantly without changing gene expression 24 h after tMCAO. Moreover, there were IC genes (iL1b, iL6, and Socs3) for PGP, as well as IC (iL6, Ccl3, Socs3, and Fos) and NC genes (Cplx2, Neurod6, and Ptk2b) for PGPL, that significantly changed in expression levels after peptide administration compared to Semax treatment under tMCAO conditions. Furthermore, gene enrichment analysis was carried out, and a regulatory gene network was constructed. Thus, the spectra of the common and unique effects of the PGP, PGPL, and Semax peptides under ischemia-reperfusion were distinguished.
Collapse
|
3
|
Glazova NY, Manchenko DM, Volodina MA, Merchieva SA, Andreeva LA, Kudrin VS, Myasoedov NF, Levitskaya NG. Semax, synthetic ACTH(4-10) analogue, attenuates behavioural and neurochemical alterations following early-life fluvoxamine exposure in white rats. Neuropeptides 2021; 86:102114. [PMID: 33418449 DOI: 10.1016/j.npep.2020.102114] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/07/2020] [Revised: 12/20/2020] [Accepted: 12/25/2020] [Indexed: 11/17/2022]
Abstract
Selective serotonin reuptake inhibitors (SSRI) are commonly used to treat depression during pregnancy. SSRIs cross the placenta and may influence the maturation of the foetal brain. Clinical and preclinical findings suggest long-term consequences of SSRI perinatal exposure for the offspring. The mechanisms of SSRI effects on developing brain remain largely unknown and there are no directional approaches for prevention of the consequences of maternal SSRI treatment during pregnancy. The heptapeptide Semax (MEHFPGP) is a synthetic analogue of ACTH(4-10) which exerts marked nootropic and neuroprotective activities. The aim of the present study was to investigate the long-term effects of neonatal exposure to the SSRI fluvoxamine (FA) in white rats. Additionally, the study examined the potential for Semax to prevent the negative consequences of neonatal FA exposure. Rat pups received FA or vehicle injections on postnatal days 1-14, a time period equivalent to 27-40 weeks of human foetal age. After FA treatment, rats were administered with Semax or vehicle on postnatal days 15-28. During the 2nd month of life, the rats underwent behavioural testing, and monoamine levels in brain structures were measured. It was shown that neonatal FA exposure leads to the impaired emotional response to stress and novelty and delayed acquisition of food-motivated maze task in adolescent and young adult rats. Furthermore, FA exposure induced alterations in the monoamine levels in brains of 1- and 2- month-old rats. Semax administration reduced the anxiety-like behaviour, improved learning abilities and normalized the levels of brain biogenic amines impaired by the FA exposure. The results demonstrate that early-life FA exposure in rat pups produces long-term disturbances in their anxiety-related behaviour, learning abilities, and brain monoamines content. Semax exerts a favourable effect on behaviour and biogenic amine system of rats exposed to the antidepressant. Thus, peptide Semax can prevent behavioural deficits caused by altered 5-HT levels during development.
Collapse
Affiliation(s)
- Nataliya Yu Glazova
- Institute of Molecular Genetics, RAS, 2 Akademika Kurchatova square, Moscow 123182, Russia.
| | - Daria M Manchenko
- Lomonosov Moscow State University, Biological Faculty, 1-12 Leninskie gori, Moscow 119234, Russia
| | - Maria A Volodina
- Lomonosov Moscow State University, Biological Faculty, 1-12 Leninskie gori, Moscow 119234, Russia; Institute of Cognitive Neuroscience, Centre for Bioelectric Interfaces, NRU HSE, 13-4 Myasnitskaya, Moscow 109028, Russia
| | - Svetlana A Merchieva
- Lomonosov Moscow State University, Biological Faculty, 1-12 Leninskie gori, Moscow 119234, Russia
| | - Ludmila A Andreeva
- Institute of Molecular Genetics, RAS, 2 Akademika Kurchatova square, Moscow 123182, Russia
| | - Vladimir S Kudrin
- Zakusov Research Institute of Pharmacology RAMS, 8 Baltiyskaya, Moscow 125315, Russia
| | - Nikolai F Myasoedov
- Institute of Molecular Genetics, RAS, 2 Akademika Kurchatova square, Moscow 123182, Russia
| | - Natalia G Levitskaya
- Lomonosov Moscow State University, Biological Faculty, 1-12 Leninskie gori, Moscow 119234, Russia; Institute of Molecular Genetics, RAS, 2 Akademika Kurchatova square, Moscow 123182, Russia
| |
Collapse
|
4
|
Shakova FM, Kirova YI, Silachev DN, Romanova GA, Morozov SG. Protective Effects of PGC-1α Activators on Ischemic Stroke in a Rat Model of Photochemically Induced Thrombosis. Brain Sci 2021; 11:325. [PMID: 33806692 PMCID: PMC8002020 DOI: 10.3390/brainsci11030325] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/23/2020] [Revised: 02/26/2021] [Accepted: 02/27/2021] [Indexed: 11/16/2022] Open
Abstract
The pharmacological induction and activation of peroxisome proliferator-activated receptor gamma coactivator 1 alpha (PGC-1α), a key regulator of ischemic brain tolerance, is a promising direction in neuroprotective therapy. Pharmacological agents with known abilities to modulate cerebral PGC-1α are scarce. This study focused on the potential PGC-1α-modulating activity of Mexidol (2-ethyl-6-methyl-3-hydroxypyridine succinate) and Semax (ACTH(4-7) analog) in a rat model of photochemical-induced thrombosis (PT) in the prefrontal cortex. Mexidol (100 mg/kg) was administered intraperitoneally, and Semax (25 μg/kg) was administered intranasally, for 7 days each. The expression of PGC-1α and PGC-1α-dependent protein markers of mitochondriogenesis, angiogenesis, and synaptogenesis was measured in the penumbra via immunoblotting at Days 1, 3, 7, and 21 after PT. The nuclear content of PGC-1α was measured immunohistochemically. The suppression of PGC-1α expression was observed in the penumbra from 24 h to 21 days following PT and reflected decreases in both the number of neurons and PGC-1α expression in individual neurons. Administration of Mexidol or Semax was associated with preservation of the neuron number and neuronal expression of PGC-1α, stimulation of the nuclear translocation of PGC-1α, and increased contents of protein markers for PGC-1α activation. This study opens new prospects for the pharmacological modulation of PGC-1α in the ischemic brain.
Collapse
Affiliation(s)
- Fatima M. Shakova
- Institute of General Pathology and Pathophysiology, Baltiyskaya Str. 8, 125315 Moscow, Russia; (Y.I.K.); (G.A.R.); (S.G.M.)
| | - Yuliya I. Kirova
- Institute of General Pathology and Pathophysiology, Baltiyskaya Str. 8, 125315 Moscow, Russia; (Y.I.K.); (G.A.R.); (S.G.M.)
| | - Denis N. Silachev
- A.N. Belozersky Research Institute of Physico-Chemical Biology, Moscow State University, Leninskye Gory 1, Bldg. 40, 119992 Moscow, Russia;
- Histology, Embryology and Cytology Department, Peoples’ Friendship University of Russia, Miklukho-Maklaya Str. 6, 117198 Moscow, Russia
| | - Galina A. Romanova
- Institute of General Pathology and Pathophysiology, Baltiyskaya Str. 8, 125315 Moscow, Russia; (Y.I.K.); (G.A.R.); (S.G.M.)
| | - Sergey G. Morozov
- Institute of General Pathology and Pathophysiology, Baltiyskaya Str. 8, 125315 Moscow, Russia; (Y.I.K.); (G.A.R.); (S.G.M.)
| |
Collapse
|
5
|
Svishcheva MV, Mishina YS, Medvedeva OA, Bobyntsev II, Mukhina AY, Kalutskii PV, Andreeva LA, Myasoedov NF. Morphofunctional State of the Large Intestine in Rats under Conditions of Restraint Stress and Administration of Peptide ACTH (4-7)-PGP ( Semax). Bull Exp Biol Med 2021; 170:384-388. [PMID: 33459919 DOI: 10.1007/s10517-021-05072-z] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/26/2020] [Indexed: 11/25/2022]
Abstract
We studied the effect of intraperitoneal administration ACTH(4-7)-PGP in doses of 5, 50, 150, and 450 μg/kg to Wistar male rats 12-15 min before modeling restraint stress on the morphofunctional state of the colon. In rats exposed to restraint stress, signs of atrophy and inflammatory reaction in the colon wall, changes in functional activity and number of mast cells, and increased serum level of corticosterone were observed. Administration of the peptide led to a decrease in corticosterone concentration, alleviated stress-induced pathomorphological changes, and promoted adaptation of the intestinal wall to stress. The positive effects of ACTH(4-7)-PGP can be determined by multifunctional nature of the physiological and pharmacological effects of the neuropeptide.
Collapse
Affiliation(s)
- M V Svishcheva
- Kursk State Medical University, Ministry of Health of the Russian Federation, Kursk, Russia
| | - Ye S Mishina
- Kursk State Medical University, Ministry of Health of the Russian Federation, Kursk, Russia
| | - O A Medvedeva
- Kursk State Medical University, Ministry of Health of the Russian Federation, Kursk, Russia
| | - I I Bobyntsev
- Kursk State Medical University, Ministry of Health of the Russian Federation, Kursk, Russia.
| | - A Y Mukhina
- Kursk State Medical University, Ministry of Health of the Russian Federation, Kursk, Russia
| | - P V Kalutskii
- Kursk State Medical University, Ministry of Health of the Russian Federation, Kursk, Russia
| | - L A Andreeva
- Institute of Molecular Genetics, Russian Academy of Sciences, Moscow, Russia
| | - N F Myasoedov
- Institute of Molecular Genetics, Russian Academy of Sciences, Moscow, Russia
| |
Collapse
|
6
|
Svishcheva MV, Mukhina AY, Medvedeva OA, Shevchenko AV, Bobyntsev II, Kalutskii PV, Andreeva LA, Myasoedov NF. Composition of Colon Microbiota in Rats Treated with ACTH(4-7)-PGP Peptide ( Semax) under Conditions of Restraint Stress. Bull Exp Biol Med 2020; 169:357-60. [PMID: 32737723 DOI: 10.1007/s10517-020-04886-7] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/10/2019] [Indexed: 01/15/2023]
Abstract
We studied the effect of Semax on the state of intestinal microbiota in rats subjected to restraint stress. Semax was injected to Wistar male rats intraperitoneally in doses of 5, 50, 150, 450 μg/kg 12-15 min before modelling chronic restraint stress. It was found that stress exposure reduced the number of obligate bacteria in the colon microbiota, but increased the content of opportunistic microorganisms. Semax in doses of 50 and 150 μg/kg prevented the stress-induced changes in the composition of colon microbiota. The observed effects of Semax might be mediated by the central neurotropic effects as well as by binding to peripheral melanocortin receptors of the intestine.
Collapse
|
7
|
Panikratova YR, Lebedeva IS, Sokolov OY, Rumshiskaya AD, Kupriyanov DA, Kost NV, Myasoedov NF. Functional Connectomic Approach to Studying Selank and Semax Effects. Dokl Biol Sci 2020; 490:9-11. [PMID: 32342318 DOI: 10.1134/s001249662001007x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/22/2019] [Revised: 07/22/2019] [Accepted: 07/22/2019] [Indexed: 11/23/2022]
Abstract
The present study was aimed at the assessment of effects of anxiolytic Selank and nootropic Semax on the whole-brain resting-state functional connectivity (FC) of each of the predefined regions of interest (ROIs) in 52 healthy participants. The ROIs included amygdala (one of the key regions for the regulation of anxiety) and dorsolateral prefrontal cortex (DLPFC; the key region for executive functions, including working memory) in the right and left hemisphere. Resting-state fMRI was carried out three times, namely before, after 5 and 20 min of the injection of either Semax, or Selank, or placebo. Between-group alongwith between-condition differences were revealed in FC between the right amygdala and a region in fusiform, inferior and middle temporal as well as parahippocampal gyri in the right hemisphere. Post hoc analysis allowed us to define both general and specific effects of Selank and Semax on FC between the right amygdala and the right temporal cortex for the first time.
Collapse
Affiliation(s)
| | | | | | | | | | - N V Kost
- Mental Health Research Center, Moscow, Russia
| | | |
Collapse
|
8
|
Elagina AA, Lyashev YD, Lyashev AY, Pronyaeva TV, Chahine AR. Correction of Lipid Metabolism Disorders in Diabetes Mellitus with Peptide Drugs. Bull Exp Biol Med 2020; 168:618-620. [PMID: 32246363 DOI: 10.1007/s10517-020-04764-2] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/05/2019] [Indexed: 11/25/2022]
Abstract
We studied the effect of peptide drugs deltalicin and Semax on lipid metabolism disturbances in diabetes mellitus. Diabetes mellitus was modeled by single injection of streptozotocin (45 mg/kg) and rats with blood glucose ≥12 mmol/liter were selected for the further experiments. Deltalicin in a dose 100 μg/kg and Semax in a dose 200 μg/kg as well as sulodexide corrected lipid metabolism disorders: the content of total cholesterol, triglycerides, LDL, index of atherogenicity decreased and HDL concentration increased. Deltalicin produced more potent effect on lipid metabolism in rats with diabetes mellitus than sulodexide and Semax, which manifested in a significant decrease in total cholesterol and LDL concentration and index of atherogenicity.
Collapse
Affiliation(s)
- A A Elagina
- Department of Pathophysiology, Kursk State Medical University, Ministry of Health of the Russian Federation, Kursk, Russia
| | - Yu D Lyashev
- Department of Pathophysiology, Kursk State Medical University, Ministry of Health of the Russian Federation, Kursk, Russia.
| | - A Yu Lyashev
- Department of Pathophysiology, Kursk State Medical University, Ministry of Health of the Russian Federation, Kursk, Russia
| | - T V Pronyaeva
- Department of Pathophysiology, Kursk State Medical University, Ministry of Health of the Russian Federation, Kursk, Russia
| | - A R Chahine
- ABC Medical Imagining, Kornishe Al-Mapraa, Beirut, Lebanon
| |
Collapse
|
9
|
Vyunova TV, Andreeva LA, Shevchenko KV, Myasoedov NF. An integrated approach to study the molecular aspects of regulatory peptides biological mechanism. J Labelled Comp Radiopharm 2019; 62:812-822. [PMID: 31325343 DOI: 10.1002/jlcr.3785] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/19/2019] [Revised: 07/09/2019] [Accepted: 07/11/2019] [Indexed: 12/11/2022]
Abstract
An integrated methodological approach to study the molecular aspects of short regulatory neuropeptides biological mechanism is proposed. The complex research is based on radioligand-receptor method of analysis and covers such points of peptides molecular activity as: specific binding of peptides to brain cells plasmatic membranes, formation of tissue specific synacton, influence of peptides (as allosteric modulators) on functionality of different neuroreceptors as well as delayed in time effects of peptides on receptor-binding activity of well-known neuroreceptor systems. Radiolabeled ligands in such complex study are the one of the best and precision instruments to uncover the molecular mechanism of multiple and multitarget biological effects of regulatory peptides. In this issue we used heptapeptide Semax as a model regulatory peptide, [3 H]Ach and [3 H]GABA as an effector molecules, and the rat model of stress-induced memory and behavior impairment as a morbid state. We showed the ability of Semax to modulate in a dose-dependent manner [3 H]Ach and [3 H]GABA specific binding to some of its corresponding receptors as well as to affect the number of [3 H]GABA specific binding places on rat neurons plasmatic membranes after complex stress exposure.
Collapse
Affiliation(s)
- Tatiana V Vyunova
- Sector of Regulatory Peptides, Department of Chemistry of Physiologically Active Substances, Institute of Molecular Genetics, Russian Academy of Sciences, Moscow, Russia
| | - Lioudmila A Andreeva
- Sector of Regulatory Peptides, Department of Chemistry of Physiologically Active Substances, Institute of Molecular Genetics, Russian Academy of Sciences, Moscow, Russia
| | - Konstantin V Shevchenko
- Sector of Regulatory Peptides, Department of Chemistry of Physiologically Active Substances, Institute of Molecular Genetics, Russian Academy of Sciences, Moscow, Russia
| | - Nikolai F Myasoedov
- Sector of Regulatory Peptides, Department of Chemistry of Physiologically Active Substances, Institute of Molecular Genetics, Russian Academy of Sciences, Moscow, Russia.,The Mental Health Research Center of the Russian Academy of Medical, Moscow, Russia
| |
Collapse
|
10
|
Samotrueva MA, Yasenyavskaya AL, Murtalieva VK, Bashkina OA, Myasoedov NF, Andreeva LA, Karaulov AV. Experimental Substantiation of Application of Semax as a Modulator of Immune Reaction on the Model of "Social" Stress. Bull Exp Biol Med 2019; 166:754-758. [PMID: 31028579 DOI: 10.1007/s10517-019-04434-y] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/04/2018] [Indexed: 11/25/2022]
Abstract
We studied immunocorrecting effects of Semax (Met-Glu-His-Phe-Pro-Gly-Pro) on the model of "social" stress caused by sensory contact and intermale confrontation. Functional activity of the immune system of laboratory animals was evaluated in standard immunopharmacological tests: delayed-type hypersensitivity reaction, direct agglutination test, latex test for studying phagocytic activity of peripheral blood neutrophils, changes in differential leukocyte count, and weight of immunocompetent organs. It was found that changes in the immune response caused by "social" stress are multidirectional, which confirms the theory of stress-induced "immune imbalance". Semax acted as effective immune corrector restoring cellular and humoral immunogenesis reactions and phagocytic activity of neutrophils. This attested to the presence of immunomodulating properties in Semax and necessitates further studies in this field.
Collapse
Affiliation(s)
- M A Samotrueva
- Astrakhan State Medical University, Ministry of Health of the Russian Federation, Astrakhan, Russia
| | - A L Yasenyavskaya
- Astrakhan State Medical University, Ministry of Health of the Russian Federation, Astrakhan, Russia.
| | - V Kh Murtalieva
- Astrakhan State Medical University, Ministry of Health of the Russian Federation, Astrakhan, Russia
| | - O A Bashkina
- Astrakhan State Medical University, Ministry of Health of the Russian Federation, Astrakhan, Russia
| | - N F Myasoedov
- Institute of Molecular Genetics, Russian Academy of Sciences, Ministry of Health of the Russian Federation, Moscow, Russia
| | - L A Andreeva
- Institute of Molecular Genetics, Russian Academy of Sciences, Ministry of Health of the Russian Federation, Moscow, Russia
| | - A V Karaulov
- I. M. Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of the Russian Federation, Moscow, Russia
| |
Collapse
|
11
|
Lebedeva IS, Panikratova YR, Sokolov OY, Kupriyanov DA, Rumshiskaya AD, Kost NV, Myasoedov NF. Effects of Semax on the Default Mode Network of the Brain. Bull Exp Biol Med 2018; 165:653-6. [PMID: 30225715 DOI: 10.1007/s10517-018-4234-3] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/25/2017] [Indexed: 10/28/2022]
Abstract
The effects of nootropic drug Semax on the neuronal network of the brain were studied by the resting state functional magnetic-resonance imaging (resting state fMRI). The study was carried out on two groups of healthy volunteers (11 men and 13 women aged 43.9±9.5 years). Resting state fMRI was carried out 3 times: directly before and 5 and 20 min after intranasal 1% Semax (14 subjects) or placebo (10 subjects). The topography of the resting state default mode network was studied. A greater volume of the default mode network rostral (medial frontal cortex) subcomponent was detected in the Semax group in comparison with controls. Resting state fMRI confirmed Semax effects on the neuronal network of the brain and demonstrated topography of these effects.
Collapse
|
12
|
Sharonova IN, Bukanova YV, Myasoedov NF, Skrebitskii VG. Modulation of GABA- and Glycine-Activated Ionic Currents with Semax in Isolated Cerebral Neurons. Bull Exp Biol Med 2018; 164:612-616. [PMID: 29577196 DOI: 10.1007/s10517-018-4043-8] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/07/2017] [Indexed: 12/01/2022]
Abstract
The concentration-clamp experiments with neurons isolated from the rat brain showed that nootropic and neuroprotective drug Semax added to perfusion solution at concentration of 1 μM augmented the amplitude of GABA-activated ionic currents in cerebellum Purkinje cells by 147±13%. In addition, Semax in perfusion solution (0.1 and 1 μM) diminished the amplitude of glycine-activated chloride currents in hippocampal pyramidal neurons down to 68 and 43% control level, respectively. Both potentiating and inhibitory effects developed slowly, and they were poorly reversible, which indicated a probable implication of second messengers in the observed phenomena. Semax accelerated the falling edge of glycine-activated current both after a short-term co-application with agonist and after addition of this peptide into perfusion solution.
Collapse
Affiliation(s)
| | | | - N F Myasoedov
- Institute of Molecular Genetics, Russian Academy of Sciences, Moscow, Russia
| | | |
Collapse
|
13
|
Gavrilova SA, Markov MA, Berdalin AB, Kurenkova AD, Koshelev VB. Changes in Sympathetic Innervation of the Heart in Rats with Experimental Myocardial Infarction. Effect of Semax. Bull Exp Biol Med 2017; 163:617-619. [PMID: 28948544 DOI: 10.1007/s10517-017-3862-3] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/07/2016] [Indexed: 11/27/2022]
Abstract
The effect of peptide Semax on remodeling of cardiac sympathetic innervation was examined in rats with experimental myocardial infarction. In 28 days after ischemia/reperfusion injury, Semax diminished the growth of sympathetic innervation of ventricular septum, although it produced no effect on the density of β1 and β2 adrenoceptors.
Collapse
Affiliation(s)
- S A Gavrilova
- Department of Physiology and General Pathology, Faculty of Fundamental Medicine, M. V. Lomonosov Moscow State University, Moscow, Russia
| | - M A Markov
- Department of Physiology and General Pathology, Faculty of Fundamental Medicine, M. V. Lomonosov Moscow State University, Moscow, Russia
| | - A B Berdalin
- Department of Physiology and General Pathology, Faculty of Fundamental Medicine, M. V. Lomonosov Moscow State University, Moscow, Russia.
| | - A D Kurenkova
- Department of Physiology and General Pathology, Faculty of Fundamental Medicine, M. V. Lomonosov Moscow State University, Moscow, Russia
| | - V B Koshelev
- Department of Physiology and General Pathology, Faculty of Fundamental Medicine, M. V. Lomonosov Moscow State University, Moscow, Russia
| |
Collapse
|
14
|
Medvedeva EV, Dmitrieva VG, Limborska SA, Myasoedov NF, Dergunova LV. Semax, an analog of ACTH (4-7), regulates expression of immune response genes during ischemic brain injury in rats. Mol Genet Genomics 2017; 292:635-53. [PMID: 28255762 DOI: 10.1007/s00438-017-1297-1] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/12/2016] [Accepted: 02/07/2017] [Indexed: 12/20/2022]
Abstract
Brain stroke continues to claim the lives of million people every year. To build the effective strategies for stroke treatment it is necessary to understand the neuroprotective mechanisms that are able to prevent the ischemic injury. Consisting of the ACTH(4-7) fragment and the tripeptide Pro-Gly-Pro (PGP), the synthetic peptide Semax effectively protects brain against ischemic stroke. However, the molecular mechanisms underlying its neuroprotection and participation of PGP in them are still needed to be clarified. To reveal biological processes and signaling pathways, which are affected by Semax and PGP, we performed the transcriptome analysis of cerebral cortex of rats with focal cerebral ischemia treated by these peptides. The genome-wide biochip data analysis detected the differentially expressed genes (DEGs) and bioinformatic web-tool Ingenuity iReport found DEGs associations with several biological processes and signaling pathways. The immune response is the process most markedly affected by the peptide: Semax enhances antigen presentation signaling pathway, intensifies the effect of ischemia on the interferon signaling pathways and affects the processes for synthesizing immunoglobulins. Semax significantly increased expression of the gene encoding the immunoglobulin heavy chain, highly affects on cytokine, stress response and ribosomal protein-encoding genes after occlusion. PGP treatment of rats with ischemia attenuates the immune activity and suppresses neurotransmission in the CNS. We suppose that neuroprotective mechanism of Semax is realized via the neuroimmune crosstalk, and the new properties of PGP were found under ischemia. Our results provided the basis for further proteomic investigations in the field of searching Semax neuroprotection mechanism.
Collapse
|
15
|
Gorbacheva AM, Berdalin AB, Stulova AN, Nikogosova AD, Lin MD, Buravkov SV, Gavrilova SA, Koshelev VB. Changes in Sympathetic Innervation of Rat Caudal Artery in Experimental Myocardial Infarction. Effect of Semax Peptide. Bull Exp Biol Med 2016; 161:476-80. [PMID: 27591879 DOI: 10.1007/s10517-016-3442-y] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/14/2015] [Indexed: 11/26/2022]
Abstract
Activation of the sympathetic nervous system aggravates the course of myocardial infarction. Semax peptide moderated the degree of this activation and prevented the increase in the density of sympathetic endings in rat caudal artery in 28 days after ischemia or ischemia/reperfusion. The peptide reduced the density of α-adrenoreceptors in the caudal artery of rats with myocardial infarction. Semax produced no effect on β-adrenoreceptors in both experimental models. The experiments on isolated segments of the caudal artery revealed reduced vascular responsiveness to electrical stimulation and norepinephrine infusion in rats treated with Semax after ischemia/reperfusion injury.
Collapse
Affiliation(s)
- A M Gorbacheva
- Department of Physiology and General Pathology, Fundamental Medicine Faculty, M. V. Lomonosov Moscow State University, Moscow, Russia.
| | - A B Berdalin
- Department of Physiology and General Pathology, Fundamental Medicine Faculty, M. V. Lomonosov Moscow State University, Moscow, Russia
| | - A N Stulova
- Department of Physiology and General Pathology, Fundamental Medicine Faculty, M. V. Lomonosov Moscow State University, Moscow, Russia
| | - A D Nikogosova
- Department of Physiology and General Pathology, Fundamental Medicine Faculty, M. V. Lomonosov Moscow State University, Moscow, Russia
| | - M D Lin
- Department of Physiology and General Pathology, Fundamental Medicine Faculty, M. V. Lomonosov Moscow State University, Moscow, Russia
| | - S V Buravkov
- Department of Physiology and General Pathology, Fundamental Medicine Faculty, M. V. Lomonosov Moscow State University, Moscow, Russia
| | - S A Gavrilova
- Department of Physiology and General Pathology, Fundamental Medicine Faculty, M. V. Lomonosov Moscow State University, Moscow, Russia
| | - V B Koshelev
- Department of Physiology and General Pathology, Fundamental Medicine Faculty, M. V. Lomonosov Moscow State University, Moscow, Russia
| |
Collapse
|
16
|
Volodina M, Sebentsova E, Glazova N, Manchenko D, Inozemtseva L, Dolotov O, Andreeva L, Levitskaya N, Kamensky A, Myasoedov N. Correction of long-lasting negative effects of neonatal isolation in white rats using semax. Acta Naturae 2012; 4:86-92. [PMID: 22708068 PMCID: PMC3372995] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022] Open
Abstract
Adverse experience during the early postnatal period induces negative alterations in physiological and neurobiological functions, resulting in long-term disorder in animal behavior. The aim of the present work was to study the long-lasting effects of chronic neonatal stress in white rats and to estimate the possibility of their correction using Semax, an analogue of ACTH fragment (4-10). Early neonatal isolation was used as a model of early-life stress. Rat pups were separated from their mothers and littermates for 5 h daily during postnatal days 1-14. The pups of the control group were left undisturbed with the dams. Half of the rats subjected to neonatal isolation received an intranasal injection of Semax at a dose of 50 µg/kg daily, from postnatal day 15 until day 28. The other animals received intranasal vehicle injections daily at the same time points. It was shown that neonatal isolation leads to a delay in physical development, metabolic disturbances, and a decrease in the corticosterone stress response in white rats. These changes were observed during the first two months of life. Semax administration weakened the influence of neonatal isolation on the animals, body weight , reduced metabolic dysfunction, and led to an increase in stress-induced corticosterone release to the control values. So the chronic intranasal administration of Semax after termination of the neonatal isolation procedure diminishes the negative effects of neonatal stress.
Collapse
Affiliation(s)
- M.A. Volodina
- Biological Faculty, Lomonosov Moscow State University
| | - E.A. Sebentsova
- Institute of Molecular Genetics, Russian Academy of Sciences
| | - N.Yu. Glazova
- Institute of Molecular Genetics, Russian Academy of Sciences
| | | | | | - O.V. Dolotov
- Institute of Molecular Genetics, Russian Academy of Sciences
| | - L.A. Andreeva
- Institute of Molecular Genetics, Russian Academy of Sciences
| | - N.G. Levitskaya
- Institute of Molecular Genetics, Russian Academy of Sciences
| | - A.A. Kamensky
- Biological Faculty, Lomonosov Moscow State University
| | - N.F. Myasoedov
- Institute of Molecular Genetics, Russian Academy of Sciences
| |
Collapse
|